Through NIAID, Fauci funded the development of Remdesivir

NIAID under Fauci funded the development of Remdesivir (GS-5735) through Grants toward a joint venture of Dr. Ralph Baric at UNC Chapel Hill and Gilead 

https://sph.unc.edu/sph-news/gillings-researchers-receive-6m-grant-to-fight-infectious-disease/

https://sph.unc.edu/sph-news/remdesivir-developed-at-unc-chapel-hill-proves-effective-against-covid-19-in-niaid-human-clinical-trials/

https://mv-voice.com/news/2020/04/29/remdesivir-drug-trials-show-patients-are-recovering-from-covid-19

https://docs.google.com/presentation/d/e/2PACX-1vSZJnxP6rZo8KJp21NSlsAbsIRFLdKz8sR_y6v57knokrISUwUEM41k1WYRqBDM9wCKvPpB-N9YygXg/pub?start=true&loop=false&delayms=60000&slide=id.p5